These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28099349)

  • 1. Development of diabetes mellitus associated with quetiapine: A case series.
    Nanasawa H; Sako A; Mitsutsuka T; Nonogaki K; Kondo T; Mishima S; Uju Y; Ito T; Enomoto T; Hayakawa T; Yanai H
    Medicine (Baltimore); 2017 Jan; 96(3):e5900. PubMed ID: 28099349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Low-Dose Quetiapine and Diabetes.
    Højlund M; Lund LC; Andersen K; Correll CU; Hallas J
    JAMA Netw Open; 2021 May; 4(5):e213209. PubMed ID: 33961038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.
    Citrome L; Jaffe A; Levine J; Allingham B; Robinson J
    Psychiatr Serv; 2004 Sep; 55(9):1006-13. PubMed ID: 15345760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of reports of quetiapine-associated hyperglycemia and diabetes mellitus.
    Koller EA; Weber J; Doraiswamy PM; Schneider BS
    J Clin Psychiatry; 2004 Jun; 65(6):857-63. PubMed ID: 15291665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.
    Sernyak MJ; Leslie DL; Alarcon RD; Losonczy MF; Rosenheck R
    Am J Psychiatry; 2002 Apr; 159(4):561-6. PubMed ID: 11925293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus during olanzapine and quetiapine treatment in Japan.
    Cohen D
    J Clin Psychiatry; 2005 Feb; 66(2):265-6; author reply 266-7. PubMed ID: 15705015
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperglycemic hyperosmolar state associated with low-dose quetiapine treatment in a patient with bipolar disorder.
    Chen WY; Chen CC; Hung GC
    Curr Drug Saf; 2011 Jul; 6(3):207-8. PubMed ID: 22122398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuation of Atypical Antipsychotic Medication During Early Pregnancy and the Risk of Gestational Diabetes.
    Park Y; Hernandez-Diaz S; Bateman BT; Cohen JM; Desai RJ; Patorno E; Glynn RJ; Cohen LS; Mogun H; Huybrechts KF
    Am J Psychiatry; 2018 Jun; 175(6):564-574. PubMed ID: 29730938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post authorization safety study comparing quetiapine to risperidone and olanzapine.
    Heintjes EM; Overbeek JA; Penning-van Beest FJ; Brobert G; Herings RM
    Hum Psychopharmacol; 2016 Jul; 31(4):304-12. PubMed ID: 27297785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New onset diabetes associated with quetiapine treatment: case report].
    Attux C; Chaves AC
    Braz J Psychiatry; 2005 Sep; 27(3):254. PubMed ID: 16224618
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of incidence of diabetes mellitus between atypical antipsychotic drugs: a survey for clozapine, risperidone, olanzapine, and quetiapine.
    Sumiyoshi T; Roy A; Anil AE; Jayathilake K; Ertugrul A; Meltzer HY
    J Clin Psychopharmacol; 2004 Jun; 24(3):345-8. PubMed ID: 15118492
    [No Abstract]   [Full Text] [Related]  

  • 12. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
    Moisan J; Grégoire JP
    Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder.
    van Winkel R; De Hert M; Wampers M; Van Eyck D; Hanssens L; Scheen A; Peuskens J
    J Clin Psychiatry; 2008 Mar; 69(3):472-9. PubMed ID: 18348593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quetiapine-related Acute Kidney Injury Requiring Transient Continuous Hemodiafiltration.
    Yamada H; Katsumori Y; Kawano M; Mori S; Takeshige R; Mukai J; Imada H; Shimoura H; Takahashi H; Horai T; Okita Y; Hirata KI
    Intern Med; 2018 Jun; 57(12):1763-1767. PubMed ID: 29434130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of permissive and restrictive pharmaceutical policies on quetiapine dispensing: Evaluating a policy pendulum using interrupted time series analysis.
    Brett J; Schaffer A; Dobbins T; Buckley NA; Pearson SA
    Pharmacoepidemiol Drug Saf; 2018 Apr; 27(4):439-446. PubMed ID: 29493050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality and morbidity following postoperative use of short-term, low-dose quetiapine vs risperidone in patients with diabetes: Analysis using a national inpatient database.
    Sato D; Uda K; Kumazawa R; Matsui H; Yasunaga H
    Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1703-1709. PubMed ID: 33111396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study.
    Østbye T; Curtis LH; Masselink LE; Hutchison S; Wright A; Dans PE; Schulman KA; Krishnan RR
    Pharmacoepidemiol Drug Saf; 2005 Jun; 14(6):407-15. PubMed ID: 15372671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical antipsychotics and new onset diabetes mellitus. An overview of the literature.
    Cohen D
    Pharmacopsychiatry; 2004 Jan; 37(1):1-11. PubMed ID: 14750042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial.
    Pagsberg AK; Jeppesen P; Klauber DG; Jensen KG; Rudå D; Stentebjerg-Olesen M; Jantzen P; Rasmussen S; Saldeen EA; Lauritsen MG; Bilenberg N; Stenstrøm AD; Nyvang L; Madsen S; Werge TM; Lange T; Gluud C; Skoog M; Winkel P; Jepsen JRM; Fagerlund B; Correll CU; Fink-Jensen A
    Lancet Psychiatry; 2017 Aug; 4(8):605-618. PubMed ID: 28599949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of diabetes mellitus associated with atypical antipsychotic use among patients with bipolar disorder: A retrospective, population-based, case-control study.
    Guo JJ; Keck PE; Corey-Lisle PK; Li H; Jiang D; Jang R; L'Italien GJ
    J Clin Psychiatry; 2006 Jul; 67(7):1055-61. PubMed ID: 16889448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.